Search results
Retinal hemorrhage: Causes, risk factors, and symptoms
Medical News Today· 4 days agoWhat is a retinal hemorrhage? Read on to learn more about bleeding in the eye, including different...
Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 4 days agoAn increase in profits from Dupixent and further uptake of Eylea HD are likely to have aided...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 1 day agoBEDFORD, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 5 days agoCognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, today announced that the company ...
Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com
ETF DAILY NEWS· 11 hours agoEquities researchers at StockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research note issued on Thursday. The brokerage set a “sell” rating ...
Obituaries in Topeka, KS | Topeka Capital-Journal
The Topeka Capital-Journal· 2 days agoMargery Adeana McClacherty at the age of 96 peacefully passed away on April 27, 2024. Margery was born on September 10, 1927, in Bellingham, Washington; daughter of the late Guy William and ...
Research Analysts Set Expectations for Adverum Biotechnologies, Inc.’s Q1 2024 Earnings...
ETF DAILY NEWS· 14 hours agoAdverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2024 earnings per share estimates for Adverum Biotechnologies in a note ...
Letters: Fluctuating costs of prescription drugs demand change
Chicago Tribune· 5 days agoUnjust and rapid prescription drug costs continue to put significant financial strain on Illinois...
Cognition Therapeutics hits enrollment goal in DLB study By Investing.com
Investing.com· 5 days agoCognition Therapeutics, Inc. (NASDAQ: CGTX), a biopharmaceutical company focused on...
Is Algae Oil the New Fish Oil?
Men's Health· 4 days agoWHILE THE IDEA of algae oil sounds pretty gross to us, the substance has been popping up left and right online recently. Could something as repulsive...
